35 Lots of Antidepressant Capsules Recalled

The capsules are indicated to treat generalized anxiety disorder, social anxiety disorder, panic disorder, and MDD
The capsules are indicated to treat generalized anxiety disorder, social anxiety disorder, panic disorder, and MDD

Zydus announced a voluntary recall of Venlafaxine HCl ER 75mg and 150mg Capsules due to an out of specification dissolution result in a retained sample. 

Venlafaxine HCl ER, the generic version of Pfizer's Effexor XR, is a selective norepinephrine reuptake inhibitor (SNRI) indicated to treat generalized anxiety disorder, social anxiety disorder, panic disorder, and major depressive disorder.  

Related Articles

The Health Hazard Evaluation (HHE) report indicated that the marginally higher dissolution rate at four and eight hour time points pose a minimal risk to the patient. The 35 affected lots include Venlafaxine HCl ER 75mg Capsules and 150mg Capsules in 30-, 90-, and 1000-count bottles. Expiration dates range from September 2017 to December 2017.

Anyone with the affected lots should discontinue further distribution and quarantine immediately.

For more information call (877) 993-8779 or visit ZydusUSA.com.

Loading links....